Beijing QL Biopharmaceutical Co., Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Dec 2040
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jul 30, 2027The maintenance fee for Fusion proteins of GDF15 and use thereof (US 11,884,711) comes due Jul 30, 2027. Unpaid by Jan 31, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 23, 2026
- Sep 1 US 12,721,897 Pharmaceutical Compositions of Polypeptide Conjugates and Methods of Uses Thereof
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 7 of 7
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,453,711 | Fusion proteins of GLP-1 and GDF15 and conjugates thereof In force · USPTO record | In force | USPTO record | |
| US 11,510,990 | Conjugates of fusion proteins of GLP-1 and FGF21 In force · USPTO record | In force | USPTO record | |
| US 11,529,394 | Polypeptide Conjugates and Methods of Uses In force · High confidence | In force | High confidence | |
| US 12,721,897 | Pharmaceutical Compositions of Polypeptide Conjugates and Methods of Uses Thereof In force · High confidence | In force | High confidence | |
| US 11,884,711 | Fusion proteins of GDF15 and use thereof In force · USPTO record | In force | USPTO record | |
| US 12,331,093 | Fusion polypeptides for metabolic disorders In force · USPTO record | In force | USPTO record | |
| US 12,383,623 | Liquid Pharmaceutical Compositions of Polypeptide Conjugates and Methods of Uses Thereof In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 1 no status recorded